Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Stock

Evening digest: Bitcoin crashes, weight-loss drug price war, Saudia’s fleet expansion

admin by admin
February 5, 2026
in Stock
0
Evening digest: Bitcoin crashes, weight-loss drug price war, Saudia’s fleet expansion
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Markets are being jolted across asset classes as risk appetite frays.

Bitcoin has cracked a key support level, deepening fears the crypto sell-off has further to run. In equities, Hims & Hers has ignited a price war in weight-loss drugs, rattling Big Pharma.

Commodities are back under pressure as gold and silver slide sharply after a volatile week.

Meanwhile, aviation heats up as Saudia weighs a historic aircraft order that could reshape global jet markets.

Bitcoin’s $67K breakdown

Bitcoin has capitulated below the critical $67,000 support, and technical analysts warn the bottom isn’t in yet.

The sell-off is being driven by a “perfect storm” of macro headwinds as Treasury Secretary Bessent’s explicit rejection of a crypto bailout, relentless ETF outflows, and over $16 billion in forced leverage liquidations.

Chart watchers are now eyeing the $62,000–$65,000 zone as the next logical floor.

With the 200-week moving average under siege and sentiment firmly in “extreme fear” territory, the market lacks the immediate buy-side liquidity to stage a reversal, suggesting this correction has more room to run.

Hims & Hers starts a weight-loss price war

Hims & Hers just nuked the GLP-1 pricing model.

By launching a compounded oral semaglutide pill for $49 a month, they aren’t just undercutting Novo Nordisk; they are brazenly challenging Big Pharma’s moat.

This is a direct shot at Novo’s newly launched oral Wegovy, which runs nearly $200 even with discounts. Investors see the threat: Novo shares slumped 6% immediately.

While Novo’s CEO dismisses the copycat as a “waste,” Hims is betting that consumers, tired of navigating insurance hurdles and shortages, will flock to a cash-pay option that costs less than a gym membership.

The regulatory fight over “compounded” drugs is about to get very ugly.

Commodities face another sell-off

Gold’s recovery attempt hit a wall on Thursday, with prices sliding back into the red as volatility continues to grip the precious metals market.

After briefly reclaiming the $5,000 level, spot gold gave up those gains to trade down 0.8% at roughly $4,926 an ounce, finding itself unable to sustain momentum against a wave of profit-taking.

Futures for April delivery mirrored the weakness, hovering near $4,942 after a wild session that saw prices swing by over $200.​

Silver, however, bore the brunt of the damage.

The metal capitulated in a violent 13% drop to around $73.60 an ounce, effectively wiping out the relief rally seen earlier in the week.

Traders are now watching the $4,700–$4,800 zone for gold as a critical line in the sand; failing to hold that floor could signal that the correction has further to run.

Saudia eyes historic fleet expansion

Saudia Airlines is negotiating a potential blockbuster order for at least 150 jets, pitting Airbus against Boeing in a winner-take-all contest.

The airline is shopping for both narrowbody and widebody aircraft to modernize its fleet and support Vision 2030’s aggressive tourism targets.

This deal would eclipse its previous record-breaking purchase of 105 Airbus jets in 2024.

While talks are early and fluid, the scale is massive, potentially reshaping order books for years.

Meanwhile, Riyadh Air is also hunting for 50 widebodies, signalling a coordinated Saudi push to dominate regional skies.

The post Evening digest: Bitcoin crashes, weight-loss drug price war, Saudia’s fleet expansion appeared first on Invezz


Previous Post

Why a $49 weight-loss pill is rattling Novo Nordisk and Eli Lilly

Next Post

Europe bulletin: BoE holds rates, Syngenta eyes IPO, Slovenia’s social media ban

Next Post
Europe bulletin: BoE holds rates, Syngenta eyes IPO, Slovenia’s social media ban

Europe bulletin: BoE holds rates, Syngenta eyes IPO, Slovenia’s social media ban

  • Trending
  • Comments
  • Latest
Starbucks to pay about $35M to NYC workers to settle claims it violated labor law

Starbucks to pay about $35M to NYC workers to settle claims it violated labor law

December 3, 2025
Gold near $5,000/oz: physical vs. paper- what’s the smarter buy?

Gold near $5,000/oz: physical vs. paper- what’s the smarter buy?

January 24, 2026
Pop Mart share price jumps after buyback, but H&S pattern points to a retreat

Pop Mart share price jumps after buyback, but H&S pattern points to a retreat

January 20, 2026
Longtime Walmart CEO to step down in January

Longtime Walmart CEO to step down in January

November 17, 2025
Qualcomm stock: why the ‘memory problem’ may be overstated

Qualcomm stock: why the ‘memory problem’ may be overstated

0
What AI bubble? Nvidia’s strong earnings signal there’s more room to grow

What AI bubble? Nvidia’s strong earnings signal there’s more room to grow

0
Bargain hunters drive Walmart sales and outlook higher

Bargain hunters drive Walmart sales and outlook higher

0
U.S. added 119,000 jobs in September, but there are signs of a weakening labor market

U.S. added 119,000 jobs in September, but there are signs of a weakening labor market

0
Qualcomm stock: why the ‘memory problem’ may be overstated

Qualcomm stock: why the ‘memory problem’ may be overstated

February 5, 2026
Commodity wrap: silver plummets 13%, gold below $4,900; oil dips on Iran talks

Commodity wrap: silver plummets 13%, gold below $4,900; oil dips on Iran talks

February 5, 2026
Nio stock just got rid of a major overhang: find out more

Nio stock just got rid of a major overhang: find out more

February 5, 2026
Microsoft stock plunges 3.5%: here are 3 big reasons why

Microsoft stock plunges 3.5%: here are 3 big reasons why

February 5, 2026

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Qualcomm stock: why the ‘memory problem’ may be overstated

    Qualcomm stock: why the ‘memory problem’ may be overstated

    February 5, 2026
    Commodity wrap: silver plummets 13%, gold below $4,900; oil dips on Iran talks

    Commodity wrap: silver plummets 13%, gold below $4,900; oil dips on Iran talks

    February 5, 2026
    Nio stock just got rid of a major overhang: find out more

    Nio stock just got rid of a major overhang: find out more

    February 5, 2026
    Microsoft stock plunges 3.5%: here are 3 big reasons why

    Microsoft stock plunges 3.5%: here are 3 big reasons why

    February 5, 2026
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved